Details for Patent: 10,835,527
✉ Email this page to a colleague
Which drugs does patent 10,835,527 protect, and when does it expire?
Patent 10,835,527 protects CONTRAVE and is included in one NDA.
This patent has forty-eight patent family members in thirty-five countries.
Drugs Protected by US Patent 10,835,527
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | FOR CHRONIC WEIGHT MANAGEMENT FOR TREATING OVERWEIGHT OR OBESITY | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,835,527
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 098631 | ⤷ Try a Trial | |||
Argentina | 120476 | ⤷ Try a Trial | |||
Australia | 2014360492 | ⤷ Try a Trial | |||
Brazil | 112016012755 | ⤷ Try a Trial | |||
Canada | 2932127 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |